HENDERSON JOHN T bought CYTK
October 16, 2026 · Form 4 insider transaction
HENDERSON JOHN T bought 352 shares of Cytokinetics, Incorporated at $63.92 per share, a transaction worth $22.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
352
Price
$63.92
Total value
$22.5K
InsiderHENDERSON JOHN T
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 16, 2026
Filing dateOctober 20, 2026
Shares owned after78,712
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Director equity in lieu of cash retainer program.